MedPath

The Natural History of Geographic Atrophy Progression (GAP) Study

Terminated
Conditions
Age-Related Macular Degeneration
Geographic Atrophy
Registration Number
NCT00599846
Lead Sponsor
Alcon Research
Brief Summary

The objective of the 18-month trial is to evaluate the natural history of geographic atrophy by assessing the rate of progression of the geographic atrophic lesion over time.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Clinical diagnosis of geographic atrophy secondary to age-related macular degeneration with no CNV lesion.
Exclusion Criteria
  • Age related

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
GA progression rate using fundus autofluorescenceFrom baseline
Secondary Outcome Measures
NameTimeMethod
GA progression rate using fundus photographyFrom baseline

Trial Locations

Locations (1)

Houston

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath